Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase EARLY_PHASE1 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Carcinoma, Endometrioid 1

Interventions

pembrolizumab 260 Cyclophosphamide 244 Specimen Handling 198 fludarabine 175 Magnetic Resonance Spectroscopy 173 Biopsy 147 Nivolumab 122 Carboplatin 99 Radiotherapy 92 Paclitaxel 88 venetoclax 82 Cisplatin 82 fludarabine phosphate 79 Gemcitabine 79 Injections 69 Ipilimumab 64 Dexamethasone 62 atezolizumab 59 Cetuximab 58 Bevacizumab 58 Azacitidine 57 Radiation 56 Fluorouracil 56 durvalumab 54 Radiosurgery 53 Temozolomide 48 Rituximab 44 Oxaliplatin 44 Docetaxel 44 Irinotecan 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × RO5126766 × 1 year × Clear all

NCT03875820 2026-03-10

FRAME

Institute of Cancer Research, United Kingdom

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡